Ex-J&J exec Warren Wang to head up Boston's Chinese operations
This article was originally published in Clinica
Executive Summary
Boston Scientific has appointed Warren Wang vice-president and managing director of its operations in China; Mr Wang was previously general manager of Johnson & Johnson's orthopaedic business in the country. He worked for J&J for over 10 years. In his new role, Mr Wang will be based at Boston's Chinese headquarters in Shanghai where he will be responsible for leading the company to "accelerated growth and further market expansion in China". Like many medtech companies, Natick, Massachusetts-based Boston is seeing higher growth outside its domestic market, particularly in emerging economies such as China. During its first fiscal quarter it posted a 4% decline in US sales, at $978m; but "inter-continental" revenues rose 10% to $205m. Overall, the firm's revenues fell 3% to $1.87bn, but this was nonetheless higher than analyst expectations (www.clinica.co.uk, 20 April 2012).